United States  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Medexus Pharmaceuticals sees fiscal 4Q revenue rocket following successful acquisitions

Proactive Investors Monday, 8 July 2019
Medexus Pharmaceuticals Inc (TSXV:MDP) (OTCQB:PDDPF) posted fiscal fourth-quarter results after the bell Monday, headlined by revenue that more than quintupled year-over-year. The drug-maker saw revenue jump to $12.7 million, up from $2.1 million in the prior-year quarter, and profit climb to $7.5 million from $0.9 million. The primary reason for the dramatic year-over-year increase are the acquisitions of Medexus Inc and Medac Pharma Inc, which each occurred within the 2019 fiscal year. READ: Medexus Pharmaceuticals adds veteran pharma executive to its board In addition, the Montreal-based company got a revenue boost from its drug portfolio. Sales of Metoject, its treatment for various types of arthritis, more than quadrupled year-over-year. Rupall, an allergy medication, saw its sales more than double. “We have made exceptional progress as an organization since the completion of the company’s transformative transactions in the fall of 2018 when we merged the businesses of Pediapharm Inc, Medexus Inc and Medac Pharma Inc,” CEO Ken d’Entremont said. “I am pleased to report we generated strong revenue growth for the fiscal fourth quarter, which was ahead of expectations given the typical seasonality of our business. Contact Andrew Kessel at [email protected] Follow him on Twitter @andrew_kessel

Recent related videos from verified sources

A Second Take on Take-Two Earnings: What Investors Must Know [Video]A Second Take on Take-Two Earnings: What Investors Must Know

All in all, investors were really excited. Take-Two Interactive beat Wall Street's estimates on revenue and earnings. Plus, management raised full-year revenue guidance. The stock rose considerably..

Credit: The Street     Duration: 00:54Published

Google Beat on Earnings -- How Much of That Was Driven By YouTube? [Video]Google Beat on Earnings -- How Much of That Was Driven By YouTube?

If Google reported Youtube results, would the stock immediately go higher? Maybe. In any event, Google beat Wall Street estimates on revenue and earnings and the stock was rising 8.10% to $1,228 a..

Credit: The Street     Duration: 01:03Published

JPM, WFC, GS Earnings: The Economy Is Strong, But There's a Caveat [Video]JPM, WFC, GS Earnings: The Economy Is Strong, But There's a Caveat

It's a mixed bag. TheStreet breaks it down. Let's go bank by bank. JPMorgan JPMorgan beat revenue and earnings per share expectations, posting revenue of $29.6 billion and EPS of $2.59. Analysts..

Credit: The Street     Duration: 00:54Published

AstraZeneca Talks Drug Pricing, Pipeline, and Path Ahead [Video]AstraZeneca Talks Drug Pricing, Pipeline, and Path Ahead

The pharmaceutical industry is firmly focused on a few key factors as of late: drug prices, M&A action, and the promise of drug pipelines. AstraZeneca , a UK-based manufacturer of numerous popular..

Credit: The Street     Duration: 05:08Published

Recent related news from verified sources

Orgenesis realigns resources with internal business transfers to support continued growth

Orgenesis Inc. (NASDAQ: ORGS) has transferred ownership of its Israeli cell process development business, Atvio Biotech Ltd., and its South Korean cell...
Proactive Investors

Universal mCloud reports 36% increase in quarter-over-quarter revenue for 2Q

Universal mCloud Corp (CVE:MCLD) (OTCQB:MCLDF), the AI and IoT group, reported organic revenue growth of 36% in its second quarter versus the previous three...
Proactive Investors

You Might Like

Other recent news in Business

RECESSION FEARS from Trump's trade war have all but ensured the Fed will cut rates further. Here are the 12 stocks Goldman Sachs says could benefit most.RV sales are plummeting, which could mean a recession is on its way — and PRESIDENT TRUMP's trade war isn't helping the struggling industry
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.